Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Cytal® Wound Matrix and MicroMatrix® for the Management of Wounds

NCT03632954 is registered in ClinicalTrials.gov with Integra LifeSciences Corporation as lead sponsor.

NCT NCT03632954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03632954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Cytal® Wound Matrix and MicroMatrix® for the Management of Wounds
Lead sponsor
Integra LifeSciences Corporation
Phase
Observational
Overall status
Terminated
Start date
December 11, 2018
Completion date
January 27, 2020
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

wounds